SecBot SecBot
PRESS-RELEASE ·Filed Oct 26, 2026
DA

DAVI

Davion Healthcare Plc
NEUTRAL
Impact 4/10
Processed46m ago Wirepress-3388005
Press release · M&A

Price Chart

Loading chart...

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3388005
4 reports for DAVI
Performance horizon
Filters
Rows
Reports for DAVI — sortable, filterable
TypeNow
Oct 26, 2026
today
Press Release
NEUTRAL ★ 4/10
$5.10awaiting T+20—$6.00 (+17.65%)
Oct 20, 2026
5d ago
6-K
NEUTRAL ★ 4/10
—awaiting T+20——
Sep 15, 2026
5w ago
6-K
NEUTRAL ★ 5/10
—awaiting T+20——
Apr 30, 2026
25w ago
20-F
NEUTRAL ★ 5/10
—awaiting T+20——
Showing 4 of 4

US Market Status

Market Closed — Opens in 1h 13m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 26, 2026

Fresh DAVI Intelligence

Analysis is for subscribers only.

Davion Healthcare Plc acquired the IP of two medical technologies (WoundSkan smart wound dressing and Spektra lateral flow test platform) from Humaskan Ltd for $25M total consideration ($2.5M cash + ~$22.5M in shares at a fixed $13.00/share contractual value). This is Davion's first acquisition…

Subscribe for Full Access